US 8383388
Modified coagulation factor IX polypeptides and use thereof for treatment
granted A61PA61P7/02
Quick answer
US patent 8383388 (Modified coagulation factor IX polypeptides and use thereof for treatment) held by Catalyst Biosciences, Inc. expires Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Catalyst Biosciences, Inc.
- Grant date
- Tue Feb 26 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 21 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 65
- CPC classes
- A61P, A61P7/02